Literature DB >> 33530344

A Comprehensive Review Evaluating the Impact of Protein Source (Vegetarian vs. Meat Based) in Hepatic Encephalopathy.

Umair Iqbal1, Ravirajsinh N Jadeja2, Harshit S Khara1, Sandeep Khurana1.   

Abstract

Hepatic encephalopathy (HE) is a common neurological consequence in patients with cirrhosis and has a healthcare burden of USD 5370 to 50,120 per patient annually. HE significantly hampers the quality of life and is a major cause of morbidity and mortality. Patients with cirrhosis are at a high risk for protein-calorie malnutrition due to altered metabolism. Current evidence has changed the old belief of protein restriction in patients with cirrhosis and now 1.2 to 1.5 g/kg/day protein intake is recommended. Case series and studies with small numbers of participants showed that a vegetarian protein diet decreases the symptoms of HE when compared to a meat-based diet, but the evidence is limited and requires further larger randomized controlled trials. However, vegetable or milk-based protein diets are good substitutes for patients averse to meat intake. Branch chain amino acids (BCAA) (leucine, isoleucine and valine) have also been shown to be effective in alleviating symptoms of HE and are recommended as an alternative therapy in patients with cirrhosis for the treatment of HE. In this review, we provide an overview of current literature evaluating the role of protein intake in the management of HE in cirrhosis.

Entities:  

Keywords:  branch chain amino acids; chronic liver disease; hepatic encephalopathy; meat protein; vegetable protein

Mesh:

Substances:

Year:  2021        PMID: 33530344      PMCID: PMC7911290          DOI: 10.3390/nu13020370

Source DB:  PubMed          Journal:  Nutrients        ISSN: 2072-6643            Impact factor:   5.717


  132 in total

1.  Hepatic encephalopathy in patients with liver cirrhosis: is there a role of malnutrition?

Authors:  Evangelos Kalaitzakis; Einar Bjornsson
Journal:  World J Gastroenterol       Date:  2008-06-07       Impact factor: 5.742

2.  Myosteatosis and sarcopenia are associated with hepatic encephalopathy in patients with cirrhosis.

Authors:  Rahima A Bhanji; Carlos Moctezuma-Velazquez; Andres Duarte-Rojo; Maryam Ebadi; Sunita Ghosh; Christopher Rose; Aldo J Montano-Loza
Journal:  Hepatol Int       Date:  2018-06-07       Impact factor: 6.047

3.  Oxindole, a sedative tryptophan metabolite, accumulates in blood and brain of rats with acute hepatic failure.

Authors:  R Carpenedo; G Mannaioni; F Moroni
Journal:  J Neurochem       Date:  1998-05       Impact factor: 5.372

4.  Colonic response to dietary fibre from carrot, cabbage, apple, bran.

Authors:  J H Cummings; W Branch; D J Jenkins; D A Southgate; H Houston; W P James
Journal:  Lancet       Date:  1978-01-07       Impact factor: 79.321

5.  Food groups and risk of hepatocellular carcinoma: A multicenter case-control study in Italy.

Authors:  Renato Talamini; Jerry Polesel; Maurizio Montella; Luigino Dal Maso; Anna Crispo; Luigi G Tommasi; Francesco Izzo; Marina Crovatto; Carlo La Vecchia; Silvia Franceschi
Journal:  Int J Cancer       Date:  2006-12-15       Impact factor: 7.396

6.  Long-term oral branched-chain amino acid treatment in chronic hepatic encephalopathy. A randomized double-blind casein-controlled trial. The Italian Multicenter Study Group.

Authors:  G Marchesini; F S Dioguardi; G P Bianchi; M Zoli; G Bellati; L Roffi; D Martines; R Abbiati
Journal:  J Hepatol       Date:  1990-07       Impact factor: 25.083

Review 7.  Refining the ammonia hypothesis: a physiology-driven approach to the treatment of hepatic encephalopathy.

Authors:  Elliot B Tapper; Z Gordon Jiang; Vilas R Patwardhan
Journal:  Mayo Clin Proc       Date:  2015-04-09       Impact factor: 7.616

8.  Benzodiazepine-associated hepatic encephalopathy significantly increased healthcare utilization and medical costs of Chinese cirrhotic patients: 7-year experience.

Authors:  Pei-Chang Lee; Ying-Ying Yang; Ming-Wei Lin; Ming-Chih Hou; Chien-Sheng Huang; Kuei-Chuan Lee; Ying-Wen Wang; Yun-Cheng Hsieh; Yi-Hsiang Huang; Chi-Jen Chu; Han-Chieh Lin
Journal:  Dig Dis Sci       Date:  2014-01-31       Impact factor: 3.199

Review 9.  Branched-chain amino acids for people with hepatic encephalopathy.

Authors:  Lise Lotte Gluud; Gitte Dam; Iñigo Les; Giulio Marchesini; Mette Borre; Niels Kristian Aagaard; Hendrik Vilstrup
Journal:  Cochrane Database Syst Rev       Date:  2017-05-18

10.  Vegetable-based dietary pattern and liver cancer risk: results from the Shanghai women's and men's health studies.

Authors:  Wei Zhang; Yong-Bing Xiang; Hong-Lan Li; Gong Yang; Hui Cai; Bu-Tian Ji; Yu-Tang Gao; Wei Zheng; Xiao-Ou Shu
Journal:  Cancer Sci       Date:  2013-08-05       Impact factor: 6.716

View more
  2 in total

1.  Is the Mediterranean Diet the Best Approach to NAFLD Treatment Today?

Authors:  Francesco Angelico; Domenico Ferro; Francesco Baratta
Journal:  Nutrients       Date:  2021-02-26       Impact factor: 5.717

2.  Management and treatment of decompensated hepatic fibrosis and severe refractory Schistosoma mansoni ascites with transjugular intrahepatic portosystemic shunt.

Authors:  Maria Cristina Carvalho do Espírito Santo; Ronaldo Cesar Borges Gryschek; Alberto Queiroz Farias; Wellington Andraus; Noêmia Barbosa Carvalho; Olavo Henrique Munhoz Leite; Felipe Corrêa Castro; Giovanni Guido Cerri; Gustavo Henrique Hypólitti; Francisco César Carnevale; André Moreira de Assis
Journal:  Rev Inst Med Trop Sao Paulo       Date:  2022-04-04       Impact factor: 1.846

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.